Invention Grant
- Patent Title: Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier
-
Application No.: US16909398Application Date: 2020-06-23
-
Publication No.: US11078293B2Publication Date: 2021-08-03
- Inventor: Hiroyuki Sonoda , Kenichi Takahashi
- Applicant: JCR Pharmaceuticals Co., Ltd.
- Applicant Address: JP Hyogo
- Assignee: JCR Pharmaceuticals Co., Ltd.
- Current Assignee: JCR Pharmaceuticals Co., Ltd.
- Current Assignee Address: JP Hyogo
- Agency: Morgan, Lewis & Bockius LLP
- Priority: JPJP2016-252148 20161226
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; C07K16/46 ; C12N9/16 ; C12N15/62

Abstract:
Provided is an anti-human transferrin receptor antibody or an analog thereof, wherein in the heavy chain variable region of the antibody, (a) CDR1 comprises the amino acid sequence set forth as SEQ ID NO: 62 or SEQ ID NO: 63, (b) CDR2 comprises the amino acid sequence set forth as SEQ ID NO: 13 or SEQ ID NO: 14, and (c) CDR3 comprises the amino acid sequence set forth as SEQ ID NO: 15 or SEQ ID NO: 16, and an analogue thereof.
Public/Granted literature
- US11111308B2 Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier Public/Granted day:2021-09-07
Information query